Skip to main content
SpringerLink
Log in

Surgical Weight Loss to Treat Atrial Fibrillation Risk and Progression

  • Arrhythmias (J. Bunch Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This review aims to examine the breadth of data associating atrial fibrillation (AF) with obesity at epidemiologic, mechanistic, and clinical levels. We then proceed to place surgical weight loss within that context.

Recent Findings

Epidemiologic studies have demonstrated a robust correlation between overweight and AF. Various mechanistic factors including concomitant risk factors, diastolic impairment, inflammation, and pericardial fat have been observed to contribute to the atrial substrate for AF. However, weight loss can institute a process of reverse atrial remodeling improving arrhythmias profile. Thus, weight loss has emerged as an indispensable aspect of effective AF management. Yet, effective weight management is often a challenging and frustrating journey for clinician and patient, raising surgical weight loss as a potential option. However, data on the role of surgical weight loss on AF are limited. Observations indicate that the dramatic and sustained weight loss availed by surgical intervention may be capable of attenuating rates of incident AF. The impact of surgical weight loss on AF populations remains unknown. However, it is likely that most of the antiarrhythmic benefits of non-surgical weight loss would be paralleled in surgical candidates, mediated by similar mechanisms. Surgical weight loss has been associated with reverse structural remodeling, improvement of diastolic function, and modulation of the autonomic profile.

Summary

There exists a compelling case for the utilization of surgical weight loss to circumvent the obstacle of treatment failure. However, resort to an invasive procedure with antedant risks for AF management alone would be premature in the absence of robust data. However, it may find a more immediate role in the context of AF ablation, where exposure to procedural risk must be justified by optimizing procedural success. Further data surrounding surgical weight loss and its antiarrhythmic benefits are required to define its role in the battle against the dual and closely linked epidemics of AF and obesity. Surgical weight loss would be a powerful weapon in the clinician’s armamentarium that would further consolidate weight loss as the fourth pillar of AF management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Wong CX, Sullivan T, Sun M, Mahajan R, Pathak R, Middeldorp ME, et al. Obesity and the risk of incident, post-operative, and post ablation atrial fibrillation. Journal of the American College of Cardiology: Clinial Electrophysiology. 2015;1:139–52.

    Google Scholar 

  2. Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the atherosclerosis risk in communities (ARIC) study. Circulation. 2011;123:1501–8.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Karasoy D, Bo Jensen T, Hansen ML, Schmiegelow M, Lamberts M, Gislason GH, et al. Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study. Europace. 2013;15:781–6.

    Article  PubMed  Google Scholar 

  4. Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish diet, cancer, and health study. Am J Med. 2005;118:489–95.

    Article  PubMed  Google Scholar 

  5. Knuiman M, Briffa T, Divitini M, Chew D, Eikelboom J, McQuillan B, et al. A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study. Eur J Epidemiol. 2014;29:181–90.

    Article  PubMed  Google Scholar 

  6. Tedrow UB, Conen D, Ridker PM, Cook NR, Koplan BA, Manson JE, et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study). J Am Coll Cardiol. 2010;55:2319–27.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sandhu RK, Conen D, Tedrow UB, Fitzgerald KC, Pradhan AD, Ridker PM, et al. Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation. J Am Heart Assoc. 2014;3:e000916.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Tsang TS, Barnes ME, Miyasaka Y, Cha SS, Bailey KR, Verzosa GC, et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J. 2008;29:2227–33.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kosiuk J, Van Belle Y, Bode K, Kornej J, Arya A, Rolf S, et al. Left ventricular diastolic dysfunction in atrial fibrillation: predictors and relation with symptom severity. J Cardiovasc Electrophysiol. 2012;23:1073–7.

    Article  PubMed  Google Scholar 

  10. Cha YM, Wokhlu A, Asirvatham SJ, Shen WK, Friedman PA, Munger TM, et al. Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function. Circ Arrhythm Electrophysiol. 2011;4:724–32.

    Article  PubMed  Google Scholar 

  11. Jais P, Peng JT, Shah DC, Garrigue S, Hocini M, Yamane T, et al. Left ventricular diastolic dysfunction in patients with so-called lone atrial fibrillation. J Cardiovasc Electrophysiol. 2000;11:623–5.

    Article  CAS  PubMed  Google Scholar 

  12. Wong CX, Sun MT, Odutayo A, Emdin CA, Mahajan R, Lau DH, Pathak RK, Wong DT, Selvanayagam JB, Sanders P, Clarke R. Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9:e004378. https://doi.org/10.1161/CIRCEP.116.004378

  13. Thanassoulis G, Massaro JM, O'Donnell CJ, Hoffmann U, Levy D, Ellinor PT, et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2010;3:345–50.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G, et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57:1745–51.

    Article  PubMed  Google Scholar 

  15. Nakatani Y, Kumagai K, Minami K, Nakano M, Inoue H, Oshima S. Location of epicardial adipose tissue affects the efficacy of a combined dominant frequency and complex fractionated atrial electrogram ablation of atrial fibrillation. Heart Rhythm. 2015;12:257–65.

    Article  PubMed  Google Scholar 

  16. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460–6.

    Article  PubMed  Google Scholar 

  17. van Rosendael AR, Dimitriu-Leen AC, van Rosendael PJ, Leung M, Smit JM, Saraste A, et al. Association between posterior left atrial adipose tissue mass and atrial fibrillation. Circ Arrhythm Electrophysiol. 2017;10:e004614 https://doi.org/10.1161/CIRCEP.116.004614

  18. Mahajan R, Lau DH, Brooks AG, Shipp NJ, Manavis J, Wood JP, et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol. 2015;66:1–11.

    Article  CAS  PubMed  Google Scholar 

  19. Mahajan R, Nelson A, Wong CX, Williams KT, Twomey DJ, Pathak R, et al. Epicardial fat depots and atrial remodelling in obese patients with atrial fibrillation: evidence for a direct pathogenic role. Heart Rhythm. 2015;12:S81–2.

    Google Scholar 

  20. Mahajan R, Lau DH, Sanders P. Impact of obesity on cardiac metabolism, fibrosis, and function. Trends Cardiovasc Med. 2015;25:119–26.

    Article  CAS  PubMed  Google Scholar 

  21. • Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-term effect of goal directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015;65:2159–69. This study examines the impact of weight loss and weight fluctuation on AF profile in a large patient cohort. Weight fluctuation attenuated the positive impacts of weight loss on AF profile, highlighting the need for sustainable weight loss to reap its anti-arrhythmic benefits.

    Article  PubMed  Google Scholar 

  22. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311:498–506.

    Article  CAS  PubMed  Google Scholar 

  23. McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, et al. Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol. 2014;7:23–30.

    Article  PubMed  Google Scholar 

  24. Ling LH, McLellan AJ, Taylor AJ, Iles LM, Ellims AH, Kumar S, et al. Magnetic resonance post-contrast T1 mapping in the human atrium: validation and impact on clinical outcome after catheter ablation for atrial fibrillation. Heart Rhythm. 2014;11:1551–9.

    Article  PubMed  Google Scholar 

  25. Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ, et al. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease. J Cardiovasc Electrophysiol. 2012;23:232–8.

    Article  PubMed  Google Scholar 

  26. Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10:90–100.

    Article  PubMed  Google Scholar 

  27. Pathak RK, Middeldorp ME, Stolcman S, Willoughby SR, Mahajan R, Lau DH, et al. Aggressive risk factor reduction study: implications for the substrate for atrial fibrillation (ARREST-AF substrate study) (Abstract). Paper presented at: Circulation. 2015;132:A14759

  28. •• Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310:2050–60. This is the only randomized study examining the impact of weight loss on AF burden. Weight loss decreases AF burden and symptoms and this effect is mediated by cardiac structural remodelling.

    Article  CAS  PubMed  Google Scholar 

  29. Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64:2222–31.

    Article  PubMed  Google Scholar 

  30. Alonso A, Bahnson JL, Gaussoin SA, Bertoni AG, Johnson KC, Lewis CE, Vetter M, Mantzoros CS, Jeffery RW and Soliman EZ. Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the look AHEAD randomized trial. Am Heart J 2015;170:770–777 e5.

  31. Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ, et al. Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm. 2012;9:473–80.

    Article  PubMed  Google Scholar 

  32. Winkle RA, Mead RH, Engel G, Kong MH, Fleming W, Salcedo J, et al. Impact of obesity on atrial fibrillation ablation: patient characteristics, long-term outcomes, and complications. Heart Rhythm. 2017;14:819–27.

    Article  PubMed  Google Scholar 

  33. Wing RR, Tate DF, Gorin AA, Raynor HA, Fava JL. A self-regulation program for maintenance of weight loss. N Engl J Med. 2006;355:1563–71.

    Article  CAS  PubMed  Google Scholar 

  34. Jeffery RW, Drewnowski A, Epstein LH, Stunkard AJ, Wilson GT, Wing RR, et al. Long-term maintenance of weight loss: current status. Health Psychol. 2000;19:5–16.

    Article  CAS  PubMed  Google Scholar 

  35. Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009;360:859–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. •• Jamaly S, Carlsson L, Peltonen M, Jacobson P, Sjostrom L, Karason K. Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects. J Am Coll Cardiol. 2016;68:2497–504. This is the only published study documenting the impact of surgical weight loss on incident AF. It observes that dramatic weight loss mediated by surgical means decreases incident AF. Additionally, the results imply that weight loss must be sustained to decrease incident AF.

    Article  PubMed  Google Scholar 

  37. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–25.

    Article  PubMed  Google Scholar 

  38. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol. 2005;45:1832–9.

    Article  CAS  PubMed  Google Scholar 

  39. Pathak RK, Elliott A, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J Am Coll Cardiol. 2015;66:985–96.

    Article  PubMed  Google Scholar 

  40. Wang TJ, Parise H, Levy D, D’Agostino RB Sr, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA : the journal of the American Medical Association. 2004;292:2471–7.

    Article  CAS  PubMed  Google Scholar 

  41. Yuan H, Miranda WR, Lopez-Jimenez F, Cha YM. The impact of bariatric surgery on incidence of atrial fibrillation. Heart Rhythm. 2014;5S:S151. (abstract)

  42. Wong CX, Brooks AG, Lau DH, Leong DP, Sun MT, Sullivan T, et al. Factors associated with the epidemic of hospitalizations due to atrial fibrillation. Am J Cardiol. 2012;110:1496–9.

    Article  PubMed  Google Scholar 

  43. Wasmund SL, Owan T, Yanowitz FG, Adams TD, Hunt SC, Hamdan MH, et al. Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study. Heart Rhythm. 2011;8:84–90.

    Article  PubMed  Google Scholar 

  44. Kurnicka K, Domienik-Karlowicz J, Lichodziejewska B, Bielecki M, Kozlowska M, Goliszek S, et al. Improvement of left ventricular diastolic function and left heart morphology in young women with morbid obesity six months after bariatric surgery. Cardiology journal. 2017;

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Royal Melbourne Hospital and the Department of Medicine, University of Melbourne, Melbourne, 3050, Australia

    C. J. Nalliah & Jonathan M. Kalman

  2. Centre for Heart Rhythm Disorders (CHRD), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia

    C. J. Nalliah & P. Sanders

Authors
  1. C. J. Nalliah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Sanders
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jonathan M. Kalman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan M. Kalman.

Ethics declarations

Conflict of Interest

Dr. Nalliah is supported by a Postgraduate Scholarship from the National Health and Medical Research Council of Australia and the National Heart Foundation of Australia.

Dr. Nalliah is also supported by the B.J Amos Traveling Fellowship from the Westmead Association, Westmead Hospital.

Dr. Kalman reports having received research funding from St Jude Medical, Biosense-Webster, Medtronic, and Boston Scientific.

Dr. Sanders reports having served on the advisory board of Biosense-Webster, Medtronic, St Jude Medical, Sanofi-Aventis and Merck, Sharpe and Dohme.

Dr. Sanders reports having received lecture and/or consulting fees from Biosense-Webster, Medtronic, St Jude Medical, Boston Scientific, Merck, Sharpe and Dohme, Biotronik, and Sanofi-Aventis.

Dr. Sanders reports having received research funding from Medtronic, St Jude Medical, Boston Scientific, Biotronik, and Sorin.

Drs Kalman and Sanders are also supported by Practitioner Fellowships from the National Health and Medical Research Council of Australia. Dr. Sanders is supported by the National Heart Foundation of Australia.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the authors.

Additional information

This article is part of the Topical Collection on Arrhythmias

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nalliah, C.J., Sanders, P. & Kalman, J.M. Surgical Weight Loss to Treat Atrial Fibrillation Risk and Progression. Curr Cardiovasc Risk Rep 11, 32 (2017). https://doi.org/10.1007/s12170-017-0559-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12170-017-0559-0

Keywords

Search

Navigation